-:SARS-CoV-2

Jing Li1,2, Kuo Zhang1,2,3, Guigao Lin1,2,3

  • 1National Center for Clinical Laboratories, Beijing Hospital/National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

PubMed
概括

CRISPR-Cas系统提供了一种快速,敏感和特定的方法来检测SARS-CoV-2变体,克服了用于COVID-19监测的基因组测序的局限性.